TP53 and ischemia: Qu et al. revealed that P53 functions as an endogenous inducer of NAT10 through transcription-dependent mechanisms during cardiac ischemia–reperfusion, thereby driving cardiomyocyte ferroptosis and aggravating ischemia–reperfusion injury [75].